임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

28건 표시

3상모집 예정· Schizophrenia; Psychosis
조현병 성인 환자에서 24주 및 52주 치료 후 크산올리딘/트로스피움(XT)의 인지장애 개선 효능 평가 연구
A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment in Adult Participants With Schizophrenia
협력: BMS
상세 →NCT07084831
3상모집 예정· Pulmonary Fibrosis
폐섬유증 환자에서 애드밀파란트의 안전성 및 내약성을 평가하는 장기 추적 연구
Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
리드: BMS
상세 →NCT07441408
4상모집 예정· Untreated Melanoma
인도의 미치료 절제 불가능 또는 전이성 흑색종 환자에서 Nivolumab + Relatlimab 고정 용량 복합제의 안전성 및 내약성 평가
A Study To Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Untreated, Unresectable or Metastatic Melanoma Participants In India
리드: BMS
상세 →NCT07459543
해당없음모집 예정· Lung Carcinoma
미국 인디언 및 알래스카 원주민 흡연자의 폐암 및 선별검사 지식 향상을 위한 교육 중재(Lung Toolkit), Lung PATHS 시험
An Educational Intervention (Lung Toolkit) for Improving Knowledge About Lung Cancer and Screening Among American Indian and Alaskan Native Cigarette Smokers, Lung PATHS Trial
협력: BMS
상세 →NCT07615764
2상모집 예정· Lymphoma
GLORY: 림프종을 위한 글로핏-젬옥스와 리소-셀
GLORY: Glofit-GemOx With Liso-Cel For Lymphoma
협력: BMS
상세 →NCT07711483
3상모집 예정· Non-Small Cell Lung Cancer
Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)
리드: BMS
상세 →NCT07680790
1/2상모집 예정· Arthritis, Rheumatoid
A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
리드: BMS
상세 →NCT07412704
3상모집 예정· Irritability Associated With Autism Spectrum Disorder
A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism Spectrum Disorder
리드: BMS
상세 →NCT07285798
3상모집 예정· Irritability Associated With Autism Spectrum Disorder
A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism
리드: BMS
상세 →NCT07284745
3상모집 예정· Schizophrenia
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
협력: BMS
상세 →NCT07686263
1상모집 예정· AQP4+ NMOSD
A Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Patients
협력: BMS
상세 →NCT07573332
2상모집 예정· Chronic Immune Thrombocytopenia
Study of Zola-cel (BMS-986353), in Participants With Autoimmune Cytopenia (Breakfree-AiCE)
리드: BMS
상세 →NCT07603557
2상모집 예정· Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
리드: BMS
상세 →NCT07680764
4상모집 예정· Healthy Volunteers
Study to Assess Safety and Tolerability of KarXT With Administration of Antiemetics in Healthy Volunteers
협력: BMS
상세 →NCT07681076
2상모집 예정· Solid Tumors
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
리드: BMS
상세 →NCT07492680
1상모집 예정· KMT2A-rearranged
Ziftomenib + Mezigdomide in Adolesc. and Adults w/ R/R AML
협력: BMS
상세 →NCT07355335
단계 미표기모집 예정· Lung Cancer
AIRCARE (Air Pollution and Cancer Research Ecosystem): Center for Advanced Research on Environmental Health and Lung Cancer Risk
협력: BMS
상세 →NCT07553598
1상모집 예정· Healthy Volunteers
Single and Multiple Dose Study to Evaluate Safety and Pharmacokinetics of BMS-986533 in Healthy Participants and Assessments of Food and pH Effects on Relative Bioavailability, and Drug-Drug Interaction Potential in Healthy Participants
리드: BMS
상세 →NCT07629999
3상모집 예정· Multiple Myeloma
Determination 2 - Isatuximab, Iberdomide, Bortezomib and Dexamethasone Induction, Followed by Risk- and Response-Adapted Consolidation and Maintenance Therapy, in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma
협력: BMS, 리제네론, 사노피
상세 →NCT07624513
1상모집 예정· Large B-cell Lymphoma
Golcadomide With Pemetrexed, Rituximab, and Dexamethasone for Relapsed and Refractory CNS Lymphomas
협력: BMS
상세 →NCT07608731
단계 미표기모집 예정· Non-Small Cell Lung Cancer
Repotrectinib Post-Marketing Surveillance in Korean Patients With ROS1-Positive Non-Small Cell Lung Cancer (NSCLC) or Solid Tumors Harboring a Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene Fusion
리드: BMS
상세 →NCT07599007
2상모집 예정· Mesothelioma
SELECTmeso A Trial for Patients With Relapsed Malignant Mesothelioma SELECTmeso1 A Trial of BMS-986504 in Patients With MTAP-deficient Relapsed Mesothelioma
협력: BMS
상세 →NCT07602946
단계 미표기모집 예정· Myelodysplastic Syndromes (MDS)
Asia Myelodysplastic Syndrome (MDS) Registry
리드: BMS
상세 →NCT07355478
2상모집 예정· Relapsed or Refractory Multiple Myeloma (RRMM)
A Phase 2, Single Arm Multicenter, Study Testing Mezigdomide, Carfilzomib, and Dexamethasone (480Kd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
협력: BMS
상세 →NCT07348393
2상모집 예정· Alzheimers Disease
The Purpose of This Study is to Evaluate the Safety and Tolerability of X/T+X-EC in Participants With Alzheimer's Disease Who Are Currently Treated With Lecanemab.
협력: BMS
상세 →NCT07212062
4상모집 예정· Schizophrenia
An Open-Label Study to Evaluate the Efficacy and Tolerability of Xanomeline/Trospium In First Episode/Early Phase Schizophrenia Patients
협력: BMS
상세 →NCT06923891
4상모집 예정· Schizophrenia Disorders
An 8-week Open-label Study of an Accelerated and Slower Switching to Xanomeline/Trospium Following Atypical Antipsychotic Treatment in Participants With Schizophrenia
협력: BMS
상세 →NCT06924255
단계 미표기모집 예정· Lung Cancer Non Small Cell
Comprehensive Demographics and Clinical Profile of NSCLC Patients
협력: BMS
상세 →NCT06725537

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.